Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Lifestyle Intervention in PCOS
NCT00151411Phase 2Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Oct 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Change in Testosterone After 6 Months of Treatment. Started Oct 2004; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT00151411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151411.